Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases
- PMID: 11051618
Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases
Abstract
The activity of mecillinam, a beta-lactam antibiotic with high affinity for gram-negative penicillin-binding protein 2 (PBP2), was assessed against ampicillin-resistant Escherichia coli strains producing beta-lactamases representing the three molecular classes, A (TEM-1 and -3, SHV-3 and IRT-5), C (AmpC) and D (OXA-3). The antimicrobial activity of mecillinam and other beta-lactam antibiotics was evaluated by determining their MICs on Mueller-Hinton agar. The time course of hydrolysis in crude extracts prepared from the various beta-lactamase-producing strains was also measured and was used to determine the relative rate of hydrolysis and the apparent affinity for ampicillin, cephalothin and mecillinam. When compared with the other beta-lactam antibiotics, mecillinam demonstrated significantly greater antibacterial potency and higher stability to beta-lactamase hydrolysis in TEM-, IRT- and AmpC-producing isolates. These findings confirm that the antimicrobial potency of mecillinam compares favourably with those of the other penicillins included in the present study, suggesting that mecillinam use in the treatment of infections caused by gram-negative bacteria should be re-evaluated.
Similar articles
-
Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.J Antimicrob Chemother. 2000 Aug;46 Suppl A:9-14. J Antimicrob Chemother. 2000. PMID: 10969046
-
Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.Int J Antimicrob Agents. 2005 Jun;25(6):479-87. doi: 10.1016/j.ijantimicag.2005.02.012. Int J Antimicrob Agents. 2005. PMID: 15894465
-
In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.Arzneimittelforschung. 1988 Jul;38(7):863-5. Arzneimittelforschung. 1988. PMID: 3061383
-
beta-Lactam resistance and beta-lactamases in bacteria of animal origin.Vet Microbiol. 2007 Apr 15;121(3-4):197-214. doi: 10.1016/j.vetmic.2007.01.015. Epub 2007 Jan 23. Vet Microbiol. 2007. PMID: 17306475 Review.
-
Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.Res Microbiol. 2004 Jul-Aug;155(6):409-21. doi: 10.1016/j.resmic.2004.02.009. Res Microbiol. 2004. PMID: 15249058 Review.
Cited by
-
Pivmecillinam with Amoxicillin/Clavulanic acid as step down oral therapy in febrile Urinary Tract Infections caused by ESBL-producing Enterobacterales (PACUTI).Trials. 2023 Sep 2;24(1):568. doi: 10.1186/s13063-023-07542-3. Trials. 2023. PMID: 37660037 Free PMC article.
-
Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.BMC Infect Dis. 2016 Nov 3;16(1):620. doi: 10.1186/s12879-016-1797-3. BMC Infect Dis. 2016. PMID: 27806687 Free PMC article.
-
High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.PLoS One. 2014 Jan 15;9(1):e85889. doi: 10.1371/journal.pone.0085889. eCollection 2014. PLoS One. 2014. PMID: 24454943 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Molecular Biology Databases
Miscellaneous